Skip to main content
Nanalysis Scientific logo

Nanalysis Scientific — Investor Relations & Filings

Ticker · NSCI ISIN · CA63000Y1034 LEI · 529900FGAUUTMJRG1255 TSXV Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CA Canada
Listing TSXV NSCI

About Nanalysis Scientific

https://www.nanalysis.com/

Nanalysis Scientific Corp. is a global developer and manufacturer of compact Magnetic Resonance (MR) technologies, primarily focusing on benchtop Nuclear Magnetic Resonance (NMR) spectrometers and analyzers. The company's proprietary instruments, such as the Nanalysis-60 and Nanalysis-100 platforms, offer accessible, affordable, and automatable high-performance alternatives to traditional high-field NMR systems. This technology democratizes NMR spectroscopy for use in laboratory and industrial settings, including applications in quality assurance/quality control (QA/QC), process analytical technology (PAT), synthetic chemistry, pharmaceuticals, polymers, and academic teaching globally.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 83% confidence The document is a certification (Form 52-109FV2) by the CEO attesting to the accuracy of the interim financial report and MD&A for the quarter ended March 31, 2026. It does not contain the actual interim financial statements or substantive financial data, but is instead an officer’s certification letter under NI 52-109. Under the Certification Rule, such documents are classified as general regulatory filings (RNS), not as the interim report itself.
2026-05-20 English
Interim MD&A - English.pdf
Management Reports Classification · 90% confidence The document is titled “Management’s Discussion & Analysis for the three months ended March 31, 2026” and contains management’s detailed explanation of quarterly financial performance, business segments, critical accounting policies, liquidity, capital resources, forward-looking statements, and operational discussion. It does not consist of the full set of interim financial statements but is the MD&A portion of the quarterly disclosure. This matches the definition for Management Reports (Code: MDA).
2026-05-20 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 94% confidence The document is titled “Interim Condensed Consolidated Financial Statements for the Period Ended March 31, 2026” and contains unaudited quarter-end financial statements (statement of financial position, loss, cash flows, changes in equity) and accompanying IFRS notes. It is a full interim (quarterly) report with substantive financial data, not merely an announcement or earnings summary. This fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-20 English
News release - English.pdf
Regulatory Filings Classification · 60% confidence The document is a press release announcing an upcoming conference call to discuss the first quarter 2026 results. It does not contain financial results itself (not an Earnings Release) nor is it a transcript or full report. It’s a general company announcement that does not fit other more specific categories, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-14 English
Material change report - English.pdf
Regulatory Filings
2026-05-06 English
News release - English.pdf
Regulatory Filings
2026-05-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.